Top

06-09-2024 | Atopic Dermatitis

Risk of incident venous thromboembolism in patients with atopic dermatitis: systematic analysis of the literature and meta-analysis

Authors: Yifei Wang, Zhiqiang Chen, Ting He, Changzheng Huang, Chen Shen

Published in: Journal of Thrombosis and Thrombolysis

Highlights

Previous studies have showed conflicting results regarding the association between atopic dermatitis (AD) and venous thromboembolism (VTE) events.

Based on our systematic review of 6 cohort studies, patients with AD have an increased risk of VTE events.

These findings provide key evidence-based estimates to inform decision-making that VTE is a comorbidity of AD.

Available only for authorised users

Langan SM, Irvine AD, Weidinger S (2020) Atopic dermatitis. Lancet 396(10247):345–360. https://doi.org/10.1016/s0140-6736(20)31286-1CrossRefPubMed

Weidinger S et al (2018) Atopic dermatitis. Nat Rev Dis Primers 4(1). https://doi.org/10.1038/s41572-018-0001-z

Eichenfield LF et al (2014) Guidelines of care for the management of atopic dermatitis: Sect. 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 70(2):338–351. https://doi.org/10.1016/j.jaad.2013.10.010CrossRefPubMed

Ascott A et al (2019) Atopic eczema and major cardiovascular outcomes: a systematic review and meta-analysis of population-based studies. J Allergy Clin Immunol 143(5):1821–1829. https://doi.org/10.1016/j.jaci.2018.11.030CrossRefPubMedPubMedCentral

Silverwood RJ et al (2018) Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study. BMJ (clinical research ed. 361. https://doi.org/10.1136/bmj.k1786

Arshad N et al (2017) Recurrence and mortality after first venous thromboembolism in a large population-based cohort. J Thromb Haemostasis: JTH 15(2):295–303. https://doi.org/10.1111/jth.13587CrossRef

Cohen AT et al (2017) Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Thromb Haemost 117(1):57–65. https://doi.org/10.1160/TH15-08-0686CrossRefPubMed

Riva N, Donadini MP, Ageno W (2015) Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation. Thromb Haemost 113(6):1176–1183. https://doi.org/10.1160/TH14-06-0563CrossRefPubMed

Tamagawa-Mineoka R et al (2008) Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4. Allergology International: Official J Japanese Soc Allergology 57(4):391–396. https://doi.org/10.2332/allergolint.O-08-537CrossRef

10.

Piazza G, Ridker PM (2015) Is venous thromboembolism a chronic inflammatory disease? Clin Chem 61(2):313–316. https://doi.org/10.1373/clinchem.2014.234088CrossRefPubMed

11.

Shaheen MS, Silverberg JI (2021) Association of inflammatory skin diseases with venous thromboembolism in US adults. Arch Dermatol Res 313(4):281–289. https://doi.org/10.1007/s00403-020-02099-6CrossRefPubMed

12.

Chen T-L et al (2022) Association of risk of incident venous thromboembolism with atopic dermatitis and treatment with Janus kinase inhibitors: a systematic review and Meta-analysis. JAMA Dermatology 158(11):1254–1261. https://doi.org/10.1001/jamadermatol.2022.3516CrossRefPubMedPubMedCentral

13.

Merola JF et al (2024) Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: a retrospective, observational, comparative cohort study using US claims data. J Am Acad Dermatol 90(5):935–944. https://doi.org/10.1016/j.jaad.2023.12.027CrossRefPubMed

14.

Afonso J et al (2023) The perils of Misinterpreting and Misusing Publication Bias in Meta-analyses: an Education Review on Funnel plot-based methods. Sports Medicine (Auckland, N.Z.) https://doi.org/10.1007/s40279-023-01927-9

15.

Meyers KJ et al (2021) Risk of venous thromboembolism among patients with atopic dermatitis: a Cohort Study in a US administrative claims database. Dermatology Therapy 11(3):1041–1052. https://doi.org/10.1007/s13555-021-00538-4CrossRefPubMedPubMedCentral

16.

Zirpel H et al (2024) Atopic dermatitis is associated with an increased risk of cardiovascular diseases: a large-scale, propensity-matched US-based retrospective study. Clin Exp Dermatol. https://doi.org/10.1093/ced/llae164CrossRefPubMed

17.

Wan J et al (2023) Incidence of Cardiovascular Disease and venous thromboembolism in patients with atopic dermatitis. The Journal of Allergy and Clinical Immunology. Practice 11(10). https://doi.org/10.1016/j.jaip.2023.08.007

18.

Warren RB et al (2023) The risk of venous thromboembolism in atopic dermatitis: a matched cohort analysis in UK primary care. Br J Dermatol 189(4):427–436. https://doi.org/10.1093/bjd/ljad212CrossRefPubMed

19.

Chen T-L et al (2023) Risk of venous thromboembolism among adults with atopic dermatitis. JAMA Dermatology 159(7):720–727. https://doi.org/10.1001/jamadermatol.2023.1300CrossRefPubMedPubMedCentral

20.

Schneeweiss MC et al (2021) Incidence of venous thromboembolism in patients with dermatologist-diagnosed chronic inflammatory skin diseases. JAMA Dermatology 157(7):805–816. https://doi.org/10.1001/jamadermatol.2021.1570CrossRefPubMed

21.

Bello N et al (2023) Systematic Literature Review and Meta-analysis of venous thromboembolism events in systemic Lupus Erythematosus. Rheumatol Therapy 10(1). https://doi.org/10.1007/s40744-022-00513-1

22.

Grainge MJ, West J, Card TR (2010) Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet (London England) 375(9715):657–663. https://doi.org/10.1016/S0140-6736(09)61963-2CrossRefPubMed

23.

Chen T-L et al (2022) Association of Psoriasis With Incident venous thromboembolism and peripheral vascular disease: a systematic review and Meta-analysis. JAMA Dermatology 158(1):59–67. https://doi.org/10.1001/jamadermatol.2021.4918CrossRefPubMed

24.

Davis DMR et al (2022) American Academy of Dermatology Guidelines: awareness of comorbidities associated with atopic dermatitis in adults. J Am Acad Dermatol 86(6). https://www.jaad.org/article/S0190-9622(22)00080-9/fulltext

25.

Brunner PM et al (2017) The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins. Sci Rep 7(1):8707. https://doi.org/10.1038/s41598-017-09207-zCrossRefPubMedPubMedCentral

26.

Réau V et al (2021) Venous thrombosis and predictors of relapse in eosinophil-related diseases. Sci Rep 11(1):6388. https://doi.org/10.1038/s41598-021-85852-9CrossRefPubMedPubMedCentral

27.

Nastałek M, Wojas-Pelc A, Undas A (2010) Plasma fibrin clot properties in atopic dermatitis: links between thrombosis and atopy. J Thromb Thrombolysis 30(2):121–126. https://doi.org/10.1007/s11239-010-0478-0CrossRefPubMed

28.

Wollenberg A et al (2020) Summary of efficacy, impact on work productivity and activity, and safety of baricitinib in moderateto-severe atopic dermatitis from two monotherapy phase III trials. British Journal of Dermatology, 183(SUPPL 1): p. 66.https://doi.org/10.1111/bjd.18968

29.

Del Duca E et al (2023) Proteomic characterization of atopic dermatitis blood from infancy to adulthood. J Am Acad Dermatol 88(5):1083–1093. https://pubmed.ncbi.nlm.nih.gov/36773824/

30.

Pavel AB et al (2020) The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature. J Am Acad Dermatol 82(3):690–699. https://doi.org/10.1016/j.jaad.2019.10.039CrossRefPubMed

31.

He H et al (2021) Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities. J Allergy Clin Immunol 147(4):1369–1380. https://doi.org/10.1016/j.jaci.2020.08.041CrossRefPubMed

32.

Hedderson MM et al (2022) Rates of cardiovascular events among patients with moderate-to-severe atopic dermatitis in an integrated health care system: a retrospective cohort study. PLoS ONE 17(11):e. https://doi.org/10.1371/journal.pone.0277469CrossRef

33.

Silverberg JI et al (2020) Validation of five patient-reported outcomes for atopic dermatitis severity in adults. Br J Dermatol 182(1):104–111. https://doi.org/10.1111/bjd.18002CrossRefPubMed

Title: Risk of incident venous thromboembolism in patients with atopic dermatitis: systematic analysis of the literature and meta-analysis
Authors: Yifei Wang
Zhiqiang Chen
Ting He
Changzheng Huang
Chen Shen
Publication date: 06-09-2024
Publisher: Springer US
Keywords: Atopic Dermatitis
Phlebothrombosis
Published in: Journal of Thrombosis and Thrombolysis
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-024-03038-2

2024 ESC Congress

Noise pollution dangerous for heart health

02-09-2024
Myocardial Infarction
News

Two studies underscore the adverse impact of noise pollution on the risk for and prognosis after myocardial infarction.

Antihypertensives: more effective at morning or night?

02-09-2024
Hypertension
News

Low Lp(a) levels unlikely to increase the risk of diabetes

02-09-2024
Type 2 Diabetes
News

» View more highlights on the 2024 ESC Congress hub page

A quick guide to ECGs

Electrocardiography
Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date.

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

At a glance: The STEP trials

Obesity
Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on modern management of frailty

Springer Medicine

Risk of incident venous thromboembolism in patients with atopic dermatitis: systematic analysis of the literature and meta-analysis

Highlights

2024 ESC Congress

Noise pollution dangerous for heart health

Post-TAVI follow up: deploying virtual assistants

Antihypertensives: more effective at morning or night?

Low Lp(a) levels unlikely to increase the risk of diabetes

» View more highlights on the 2024 ESC Congress hub page

A quick guide to ECGs

At a glance: The STEP trials

Keynote webinar | Spotlight on modern management of frailty

Springer Medicine

Highlights

Please log in to get access to this content

2024 ESC Congress

Noise pollution dangerous for heart health

Post-TAVI follow up: deploying virtual assistants

Antihypertensives: more effective at morning or night?

Low Lp(a) levels unlikely to increase the risk of diabetes

» View more highlights on the 2024 ESC Congress hub page

A quick guide to ECGs

At a glance: The STEP trials